Issue Date Type Title Author(s) 1 1-Jan-2025 Article Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics Lazaridou, Elizabeth Apalla, Zoe Ravanidis, Stylianos Stefanou, Garyfallia Vellopoulou, Katerina et al
2 1-Dec-2024 Article Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020–2023 versus 2016–2019 in a Nation-Wide Cohort Study Bournia, Vasiliki-Kalliopi Fragoulis, George E. Mitrou, Panagiota Tsolakidis, Anastasios Mathioudakis, Konstantinos et al
3 1-Dec-2024 Conference Paper Persistence rates of second-line biologics in psoriasis following first-line biologic treatment based on nationwide data from Greece Ravanidis, Stylianos Stefanou, Garyfallia Tsolakidis, Anastasios Mathioudakis, Konstantinos Lazaridou, Elizabeth et al
4 1-Dec-2024 Conference Paper Cost of biologics in patients suffering from psoriasis in Greece: a retrospective longitudinal cohort study Stefanou, Garyfallia Vellopoulou, Katerina Tsolakidis, Anastasios Mathioudakis, Konstantinos Lazaridou, Elizabeth et al
5 1-Sep-2024 Article A real-world retrospective study on biologics utilization in patients with psoriasis in Greece during the period 2015–2020 Lazaridou, Elizabeth Kourlaba, Georgia Lampropoulou, Dimitra Ioanna Gounelas, George Tsolakidis, Anastasios et al
6 6-Jul-2024 Article Drug survival of biologics in patients with psoriasis: real-world evidence for Greece during the period 2016–2020 Lazaridou, Elizabeth Kourlaba, Georgia Ravanidis, Stylianos Gounelas, George Stefanou, Garyfallia et al
7 1-Jun-2024 Article Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database Terentes-Printzios, Dimitrios Dima, Ioanna Benardos, Panorios Mitrou, Panagiota Mathioudakis, Konstantinos et al
8 16-Apr-2024 Article Prevalence and incidence of medication-treated diabetes and pattern of glucose-lowering treatment during the COVID-19 pandemic: real-world data from the electronic Greek prescription database Siafarikas, Christos Karamanakos, George Makrilakis, Konstantinos Tsolakidis, Anastasios Mathioudakis, Konstantinos et al
9 1-Apr-2024 Article Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study Bournia, Vasiliki-Kalliopi Fragoulis, George E. Mitrou, Panagiota Mathioudakis, Konstantinos Konstantonis, George et al
10 1-Mar-2023 Article Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study Bournia, Vasiliki-Kalliopi Fragoulis, George E. Mitrou, Panagiota Mathioudakis, Konstantinos Tsolakidis, Anastasios et al
11 1-Dec-2022 Article Prevalence and patterns of anti-osteoporotic drug use based on 2019 real-world nationwide data in Greece Yavropoulou, Maria Makras, Polyzois Athanasakis, Kostas Bournia, Vasiliki-Kalliopi Mathioudakis, Konstantinos et al
12 1-Sep-2022 Conference Paper Prevalence and incidence of treated diabetes during the COVID-19 pandemic: real-world data from the Greek national electronic prescription database Siafarikas, Christos Karamanakos, George Makrilakis, Konstantinos Mathioudakis, Konstantinos Tsolakidis, Anastasios et al
13 1-Jan-2022 Conference Paper Impact of comorbidities on patterns and annual cost of anti-osteoporotic drug treatment based on real-world nation-wide data on 8,641,341 individuals Yavropoulou, Maria Makras, Polyzois Anastasilakis, Athanasios Athanasakis, Kostas Bournia, Vasiliki-Kalliopi et al
14 1-Jan-2022 Conference Paper Current prevalence and patterns of anti-osteoporotic drug use based on real-world nation-wide data on 8,641,341 individuals Yavropoulou, Maria Makras, Polyzois Athanasakis, Kostas Bournia, Vasiliki-Kalliopi Mathioudakis, Konstantinos et al
15 2-Nov-2021 Article All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019 Bournia, Vasiliki-Kalliopi Fragoulis, George E. Mitrou, Panagiota Mathioudakis, Konstantinos Tsolakidis, Anastasios et al
16 25-Sep-2020 Article Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: Data on 42 815 real-world patients with inflammatory rheumatic disease Bournia, Vasiliki-Kalliopi Tektonidou, Maria G. Vassilopoulos, Dimitrios Laskari, Katerina Panopoulos, Stylianos et al